Updated investor presentation final

  • Published on
    13-Jan-2017

  • View
    79

  • Download
    1

Embed Size (px)

Transcript

<ul><li><p>Carmike Cin emas Inc Exhib it 99 1</p></li><li><p>AMCs acq uisi tion of Carmike: Transaction overview Price per share On 3/3 /16 Carmike agreed to be acq uired by AMC for $30 00 in cash p er sh are for each outstanding share of Carmikes common stock Equity valu e2 $756 mill ion E nterprise value3 $1 115 million Anticipated timin g The transact ion will be put to vote du ring th e special stockho lder meeting o n June 30 2016 Expected to be comp leted by the end of 2016 Fully committed financing Fully co mmitted financin g pack age prov ided by Cit i Funded th rou gh a combinat ion of A MCs existing liquidi ty including cash on hand an d incremental debt 1 Based on LTM 1 2/31/15 reported EBITDA of $126mm adjus ted to include stock-b ased compensatio n and expenses related to M&amp;A 2 At announ cement; based on 2 4 6mm shares outs tandin g with 0 6mm in-the-money options and RSUs as of 3/3/16 3 Adds n et debt as of 12/31/1 5 of $359mm to equity value as per the 2015 10K filed o n 2/2 9/16 comprised of $2 30mm in p rincipal amoun t of senio r secured notes an d $231 mm in capital lease obligatio ns as reduced by a cash balance of $1 02mm Tran saction multiple1 8 8 x LTM E BITDA at annou ncement</p></li><li><p>Transact ion max imizes v alue for Carmike sto ckh olders Outsized imp lied offer mult iple comp ared to historical trad ing multiples Offer price implies 8 0x 20 16E consensu s EBITDA1 Notably higher th an Carmikes average forward trad ing multiple over the past 1- 2- 3- 5- and 10 -y ears FV / 20 17E consensu s EBITDA: 7 4x H ighest large-scale tran sact ion multiple in the sector in the past 10 years Offer price implies 8 8x LTM EBITDA at 12/31 /2015 Significantly higher mu ltiple than 7 1x LTM EBITDA paid by Wanda to acquire AMC in 2012 Higher than 8 6x LTM EBITDA paid b y Cinemark to acquire Century Theatres in 200 6 Delivers valu e and certainty to stockholders In evalu at ing all av ai lable alternatives Carmikes Board con sidered the risks an d challenges associated with i ts growth plan Sig nifican t ind ustry consolid at ion h as impacted th e p ipeline of acquis itio n oppo rtunit ies An all-cash transactio n provid es certainty and liquidi ty at a premium given these poten tial risks and appropriately co mpensates Carmike's stockho lders fo r Carmikes stak e in Screen vision Objective and thoroug h process Bo ard u nan imou sly approv ed tran saction after thorough co nsideration of al l available alternatives Board was advised by its financial advisor J P Mo rg an an d legal advisor King &amp; Spaldin g throug hout the process $30 00 offer is the only offer received fol lowin g market checks with al l reaso nab ly l ikely bu yers from December 2014 through March 2015 and in Feb ru ary 2 016 No topping bid or subs tantial interes t has su rfaced from any strategic or financial bu yer s ince mark et ch ecks b egan in Decemb er 20 14 The Board u nanimo usly determined that the transact ion is in the best interes t of stock holders and reflects the culminatio n of a co mprehen sive multi -y ear effort to maximize stockho lder value 1 Based o n consensus projected 2016 E EBITDA of $1 40mm as of 3/3/16 1 2 3 4</p></li><li><p>Outs ized imp lied offer multiple compared to h isto rical trading multiples His torical valuation: FV / NTM EBITDA So urce: FactSet Comp an y filin gs and equity research as of 6/9 /16 No te: Analys is excludes Cineplex because of alternate lin es of busin ess (gaming altern ate p ro gramming etc ) May-16 Carmike has co nsis tently trad ed at a d iscount to p eers $30 00 per share represents 8 0x 201 6E consensus EBITDA Th is multiple rep resents a significant ly higher valuation than Carmikes average forward trading mu ltip le over the past 1 - 2- 3- 5- and 10-years / : 8 0x 20 16E consensus EBITDA 1 No re-ratin g has occurred s ince ann ouncement of th e transaction with unaffected relevant comp arable companies con tinu ing to trade in-line with h isto rical averag es CKEC 7 2x RGC 8 7x AMC 7 7x CNK 7 6x CKEC 7 8x RGC 7 9x AMC 7 8x CNK 7 5x 3 /3/16 Carmikes acquisit ion anno unced Carmikes NTM multip le as of 3/3/16 was 7 2x</p></li><li><p>Averag e histo rical NTM trading multiple v s peers 1-year average Carmikes discoun t (1 1x) 17 % 17% 15% 1 7% 16% 21% 1 8% 3-year average 5-year av erage 10-year average (1 4x ) (1 4x) (1 2x) (1 4x) (1 2 x) (1 6x) (1 4x) 1 Carmike has traded at a disco unt to peers over almost al l relevan t timeframes No reason to believe th at the standalo ne discoun t would chan ge in th e future g iven th e fund amen tal differences between Carmik es theatre circuit and operations and peers Outsized implied o ffer mult iple comp ared to historical trading mult iples (contd )</p></li><li><p>Implied Carmike share price based on average h isto rical NTM EBITDA trading mult iples 1 7% 17% 15% 1 7% 16% 21 % 18% Carmike price as of 3/3/16 : $25 11 Offer price: $30 00 5-year average 10-year average 3-year average 1-year average Unaffected (3/3/16) Source: FactSet as o f 6 /9/1 6 Co mpany p ress releases Note: Implied share price calculat ion assumes net d ebt of $374 mm and the basic shares outstandin g of 24 55 mm diluted at various implied prices (As per the Carmike 10Q filed o n 5/2/16) 1 Based on NTM EBITDA of $1 43mm based on med ian street consensus as of 6/9/16 No re-rating of relevant tradin g comparab les has occurred s ince ann ouncement of th e transaction with unaffected relevan t comparable companies con tinu ing to trade in-lin e with h isto rical averag es Applying Carmikes unaffected and historical t radin g averages to street consensus NTM EBITDA estimates would imp ly a value of $19 79 to $25 98 per share for Carmikes stock 1 Ou tsized implied offer multiple compared to his torical trading multiples (contd)</p></li><li><p>($mm) TV/LTM EBITDA Mean: 6 5x Med ian: 5 9 x 8 8x LTM EBITDA So urce: Public fi lin gs equity research Tran sact ion valu e ($mm): $1 115 $ 2 600 $ 1 041 Acquirer: T arget: Screens: 2 95 4 4 865 1 017 TV / Screen ($000s) $ 377 $5 34 $1 0 24 Transact ion v alue ($ mm): 2 600 1 041 $3 6 172 6 7 32 1 91 52 2 38 13 9 1 240 1 19 277 49 210 34 Acquirer: Target: Lo cations: 338 77 5 33 2 1 9 26 2 0 43 7 25 32 1 6 92 4 28 4 Other transactions for smaller scale th eatre chains typically valued between 5 0-6 5x LTM EBITDA 2 Hig hest large-scale transactio n multip le in the secto r in th e past 10 years</p></li><li><p>Mean: 6 5x Median : 5 9x 8 8x LTM EBITDA Sou rce: FactSet as of 3/3/16 Pub lic filings equity research Note: Attendance Revenue and Adj EBITDA p er screen metrics are calculated us ing averag e screen s for trai lin g twelve mo nths; Adj EBITDA as reported Transact ion v alue ($ mm): 2 600 1 041 $3 6 172 6 7 32 19 1 52 2 38 13 9 1 240 1 19 277 49 210 34 Acquirer: Target: Lo cations: 338 77 5 33 2 1 9 26 2 0 43 7 25 32 1 6 92 4 28 4 2 Highest larg e-scale transact ion mult iple in the sector in the past 10 years (contd) Carmikes disco unt vs peers (54 %) (58 %) (63 %) Firm v alue / Number of screen s (in $0 00s) Comparing transaction value / screen of the Carmike deal to i ts p eers is not meaningful given Carmikes circui t is focused o n rural en d markets Compared to u rb an end markets rural end markets exh ibit lower per screen admission s and concession s collection s Addition al ly Carmikes circu it features theatres which becau se of their age will requ ire g reater levels of go-forward investment relative to the circuits of Carmik es p eers A comp arison of key per screen op erating metrics with peers high ligh ts Carmikes differentiated circui t focus: T his fact is furth er il lustrated by the chart below wh ich shows Carmik es firm value / screen cou nt was well below its peers the day prio r to the deal</p></li><li><p>Source: FactSet as of 3/3/16 Company p ress releases Share price performance over time 4/1/09: $2 55 Note: VWAPs calculated as o f 3 /3/16 3/13 /15 Reuters article rep orts Carmike is exp loring a sale p rocess; ru mor driv es share price to $34 05 - +10% in one day 3 /3/16 : $25 11 $30 00 offer 2/29/1 6 Anno unces 4Q15 results which o utperfo rm street estimates giv en strong b ox perfo rman ce and lower o peratin g costs share p rice rises +15 % on th e next day 3 Deliv ers v alue and certainty to stockholders Share performance driven by uniqu e combination of events: Stro ng 201 3 box o ffice results across the indu stry Ann ounced acquisit ion o f Digiplex in May 2014 NCM/Screenvision tran sact ion anno unced in May 2 014 wh ich would have provided Carmike ~ $70mm in p re-tax proceed s</p></li><li><p>Source: FactSet Company filings equity research and Box Office Mojo as of 6/9/16 Note: Analysis excludes Cineplex becau se of al tern ate l ines of bu siness (gaming alternate programming etc ) DBO fo r Ap r 2015 DBO for Dec 2 016 Apr &amp; May 20 16 Key misses: Batman vs Superman $325 mm v s $38 0mm exp ected; Alice Through the Looking Glass opening weekend o f $2 9mm vs $3 5mm exp ected Q1 2016 DBO stronger than expected due to carry over from Star Wars and outperformance from Deadp ool and Z ootop ia Q2 2015 DBO soft before release of Jurassic World (flat vs +8% estimates ) d ue to und erperfo rmance from Aveng ers 2 and Tomo rrowland Q4 201 5 Better than expected DBO primari ly driven by Star Wars wh ich resulted in a record DBO year $/share (rebased to Carmikes stock p rice) DBO $mm In dustrys stock price performance is correlated to the Domestic box o ffice ex pectations 3 Delivers value and certainty to stock holders (contd) Carmike AMC Cinemark Regal 3 month forward monthly DBO 3 mon th forward projected monthly DBO $30 offer deliv ers v alue and certainty to s tockholders again st an un certain b ox office b ackdrop</p></li><li><p>Select analys t commen tary 2Q1 6 Domestic Box Office: We now est imate that the ind ustry bo x office benchmark for th e qu arter wil l likely end do wn -11% (had been -3%) Quarter to date the ind ustry is down 9% an d at a high level while we v iew "Finding Dori" as generating a stron ger b ox office than "Inside Out" from last y ear the aggregate box office remaining from "X-Men: Ap ocalypse" "Teenage Mu tant Ninja Turtles 2 p lus "Indepen den ce Day 2" will lik ely under perform "Ju rassic Wo rld" Stifel 06/09 /16 With the QTD box tracking down ~3 5 % YoY we are lo werin g 2Q box es t from do wn 1% to down 3-4%: Despite stro ng perfo rman ce from The Jungle Book and Captain America: Civi l War tough YoY tent-po le comps u nderp erformance of Hu ntsman an d Keanu an d a faster th an ex pected d ecay in 2 Q fo r Batman v s Superman have led the box office to track d own ~3 5% (as of May 15) We continue to see do wnside to co nsensus es timates for 2 H16 and 201 7 Morgan Stanley 05/20 /16 The 2Q bo x office is now expected to come in at ~$2 8b n down 8-9% year-over-y ear This is a bi t so fter th an previously anticip ated Key drivers were April not h aving much outs ide of Jung le Boo k and May n ot havin g much o utside of Captain America: Civi l War where th e b ox office was a bit softer th an anticipated (tho ught s til l st ron g ) Key underperformers included Batman vs Superman (which gen erated $32 5 vs expectatio ns for $380 mm) Hun tsman and Neighbors 2 RBC Capital Mark ets 05/27/16 Key observation s Bo x office revenues witnessed 7 4% growth in 2015 wh ile 2016 is p rojected to decline by 3 0% to $10 8 b ill ion Th e d ecline is mainly driven by und erperfo rming fi lms such as Alice Throug h the Loo king G lass and Hun tsman as well as a weaker slate comp ared to last year Box office rev en ues co ntin ue to be driven b y the to p grossing films Th e To p 3 and Top 10FactSet equity research</p></li><li><p> Wedbush 04/06/16 Macquarie 04/0 3/16 RBC Capital Mark ets 03/08/16 Macquarie 03/0 4/16 We believe AMC will complete i ts acquis ition of Carmike by th e end of 2 016 AMC intends to acq uire al l outstanding sh ares of Carmike fo r $ 30 per share in cash valuing Carmike at $1 1 b ill ion including debt We believ e this is a reason able valuation and do no t expect a higher outside bid prior to the closing of th e acquis ition at th e end of 2 016 We struggle to identify a potential bidd er th at would offer a higher price than AMC's current $30 offer As a resul t we don 't see Carmike having leverage to d rive a higher offer price from AMC At this point we ex pect A MC's acquisi tio n of Carmike g o throu gh at AMC's cu rrent o ffer We believe the two co mpanies form a perfect marriage that will be app rov ed from an FTC stand point and shareholder stand point While the stock was trading above these levels last year (wh en there was speculat ion o f a po ssible sale) we believ e $ 30 is a fair price The deal is expected to close by the end of 2016 We thin k the deal works for bo th stocks as AMC is acquiring a sizable circuit at an at tract ive valuatio n with potent ial for synergy up side while Carmik e shareholders are getting taken ou t at a premium multip le The deal values Carmike at 8 5x our 2016 EBITDA estimate a sig nifican t premiu m to the ~6 5x EV/FTM EBITDA th at we est imate CKEC h as trad ed at over the lon g-term Wed bush 0 4/06/16 Macqu arie 03 /04/16 RBC Capital Markets 03/08 /16 RBC Cap ital Markets 03/0 4/16 Ind ep end ent analysts suppo rt ive of value achieved with no expectation of a competing bid Select Carmik e analys t reactions Select AMC an alyst react ions 3 Delivers value and certainty to stockhold ers (contd)</p></li><li><p>The Board careful ly comp ared the po tential ben efits and risk s of Carmik es s tandalone plan to AMCs $3 0 all cash offer among the Boards consideratio ns were: Industry structure Carmikes scale foo tprint an d strategy relativ e to competi tors Invest ing in upg rades to ex isting th eatres Competi tio n to attract declin ing n umber of theatre-go ers Requires significant investment to del iver enh anced customer ex perience Bu ilding new th eatres requires significant capex Carmike theatre averag e age = 17 years Closures offsetting organic growth from new openin gs Acquis itions Availab ili ty timin g price value impact difficult to predict Pace is slowing (acqu ired 746 screen s fro m 2011-2 014 bu t only 59 screen s in the 18 months prior to ann ouncing the AMC transact ion) 3 Delivers value and certainty to sto ck holders (contd) The Board unanimously co ncluded th at the certain value of the all cash $3 0 per share transaction rep resented b et ter risk-ad justed value fo r Carmikes stockhold ers than all other alternatives Key metrics Source: Co mpany fil ings 1 Adj EBITDA as reported 2 Includ es cash spent on acquisitions 2 1</p></li><li><p>At the direct ion o f the Board and management J P Morgan thoroughly assessed third-party in terest in particip at ing in the sale process Dec 2014 Feb 20 16 Jan 20 15 April 2015 Jan 2016 Carmike contacts p arties A B C D and E : Party B C D and E d ecline to execu te co nfidentially agreements and pass o n the op portuni ty Party A executes co nfidentiali ty agreemen t and is provid ed data roo m access AMC informs Carmike it is no longer in terested in pursu ing a po tential t ransaction AMC approach es Carmik e to ask abou...</p></li></ul>